NCT02688101View on ClinicalTrials.gov

Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 11, 2016

Primary Completion Date

October 26, 2017

Study Completion Date

October 26, 2017

Conditions
Neoplasms
Interventions
DRUG

DpC

iron chelator

Trial Locations (4)

Unknown

Lifehouse Cancer Treatment Centre, Sydney

Olivia Newton John Cancer Centre, Heidelberg

Monash Cancer Center, Melbourne

Peter MacCallum Cancer Centre, Melbourne

Sponsors
All Listed Sponsors
lead

Collaborative Medicinal Development Pty Limited

INDUSTRY

NCT02688101 - Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter